Evidence map›Paper›PMID 38409228›Full record

ArticleNature communications2024

Whole-exome sequencing in UK Biobank reveals rare genetic architecture for depression.

Ruoyu Tian, Tian Ge, Hyeokmoon Kweon, Daniel B Rocha, Max Lam, Jimmy Z Liu, Kritika Singh, Biogen Biobank Team, Daniel F Levey, Joel Gelernter and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Polygenic scores in psychiatric research and clinical practice.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Probing neuropsychiatric disorders through in vivo CRISPR screening.Current opinion in genetics & development · 2026
    Review
  9. Frontiers in behavioral neuroscience · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Ruoyu TianBiogen Inc, Cambridge, MA, USA.
Tian GePsychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Hyeokmoon KweonDepartment of Economics, School of Business and Economics, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Daniel B RochaPhenomics Analytics and Clinical Data Core, Geisinger Health System, Danville, PA, USA.
Max LamStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-4256-7844
Jimmy Z LiuBiogen Inc, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8379-5480
Kritika SinghDivision of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Biogen Biobank Team
Daniel F LeveyDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-8431-9569
Joel GelernterVA Connecticut Healthcare Center, West Haven, CT, USA.ORCID http://orcid.org/0000-0002-4067-1859
Murray B SteinVA San Diego Healthcare System, San Diego, CA, USA.ORCID http://orcid.org/0000-0001-9564-2871
Ellen A TsaiBiogen Inc, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5625-1189
Hailiang HuangStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1461-5762
Christopher F ChabrisAutism & Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA, USA.
Todd LenczDivision of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.ORCID http://orcid.org/0000-0001-8586-338X
Heiko RunzBiogen Inc, Cambridge, MA, USA. heiko.runz@gmail.com.ORCID http://orcid.org/0000-0002-2133-7345
Chia-Yen ChenBiogen Inc, Cambridge, MA, USA. chiayenc@gmail.com.ORCID http://orcid.org/0000-0001-9548-5597
Biogen (United States) · USBroad Institute · USYale University · USAutism & Developmental Medicine Institute · USGeisinger Health System · USNorthwell Health · USVanderbilt University Medical Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Cognitive Genomics as a Window on Neurodevelopment and PsychopathologyR01MH117646 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI TODD LENCZ · 2018 to 2026
$4.7M
PsycheMERGE: Leveraging electronic health records and genomics for mental health researchR01MH118233 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI DAVIS, LEA K, SMOLLER, JORDAN W · 2019 to 2022
$3.1M
NCATS NIH HHS UL1 TR001863NIMH NIH HHS R01 MH117646NIMH NIH HHS R01 MH118233
6 · The paper itself

Abstract

Nearly two hundred common-variant depression risk loci have been identified by genome-wide association studies (GWAS). However, the impact of rare coding variants on depression remains poorly understood. Here, we present whole-exome sequencing analyses of depression with seven different definitions based on survey, questionnaire, and electronic health records in 320,356 UK Biobank participants. We showed that the burden of rare damaging coding variants in loss-of-function intolerant genes is significantly associated with risk of depression with various definitions. We compared the rare and common genetic architecture across depression definitions by genetic correlation and showed different genetic relationships between definitions across common and rare variants. In addition, we demonstrated that the effects of rare damaging coding variant burden and polygenic risk score on depression risk are additive. The gene set burden analyses revealed overlapping rare genetic variant components with developmental disorder, autism, and schizophrenia. Our study provides insights into the contribution of rare coding variants, separately and in conjunction with common variants, on depression with various definitions and their genetic relationships with neurodevelopmental disorders.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyBiological Specimen BanksDepressionExome SequencingHumansUK Biobank

Identifiers

PMID38409228
PMCPMC10897433
OpenAlexW4392162661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.